title: Probiotics for recurrent Clostridium difficile disease.
authors.affiliation: Division of Infectious Diseases, Washington University School of Medicine, Box 8051, 660 South Euclid Avenue, St. Louis, MO 63110, USA 2Division of Gastroenterology, Harvard Medical School, Boston, MA, USA 3Philadelphia FIGHT, Philadelphia, PA, USA 4Saint Louis University School of Public Health, St. Louis, MO, USA.
authors.forename: Steven J
authors.initials: SJ
authors.lastname: Lawrence
authors.affiliation: Division of Infectious Diseases, Washington University School of Medicine, Box 8051, 660 South Euclid Avenue, St. Louis, MO 63110, USA 2Division of Gastroenterology, Harvard Medical School, Boston, MA, USA 3Philadelphia FIGHT, Philadelphia, PA, USA 4Saint Louis University School of Public Health, St. Louis, MO, USA.
authors.forename: Joshua R
authors.initials: JR
authors.lastname: Korzenik
authors.affiliation: Division of Infectious Diseases, Washington University School of Medicine, Box 8051, 660 South Euclid Avenue, St. Louis, MO 63110, USA 2Division of Gastroenterology, Harvard Medical School, Boston, MA, USA 3Philadelphia FIGHT, Philadelphia, PA, USA 4Saint Louis University School of Public Health, St. Louis, MO, USA.
authors.forename: Linda M
authors.initials: LM
authors.lastname: Mundy
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D016360:Clostridioides difficile / Q000187:drug effects*; D004359:Drug Therapy, Combination; D004761:Enterocolitis, Pseudomembranous / Q000188:drug therapy* / Q000517:prevention & control*; D005260:Female; D006801:Humans; D007778:Lactobacillus; D008297:Male; D010865:Pilot Projects; D019936:Probiotics / Q000008:administration & dosage*; D055502:Secondary Prevention; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents